Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma.

Based on a limited number of patients, we propose that a response to treatment is more likely to be associated with a longer survival compared to stable disease or progressive disease, although this did not reach statistical significance.

also in 111,027 other papers